Dr Shawn Wade Bryant, PSYD | |
839 W. Court St., Suite 4, Beatrice, NE 68310 | |
(402) 228-6446 | |
(402) 228-0394 |
Full Name | Dr Shawn Wade Bryant |
---|---|
Gender | Male |
Speciality | Psychologist - Clinical |
Location | 839 W. Court St., Beatrice, Nebraska |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1528237112 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
103TC0700X | Psychologist - Clinical | LP0549 (Nebraska) | Primary |
Entity Name | Beatrice Community Hospital & Health Center Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1922111855 PECOS PAC ID: 1951208222 Enrollment ID: O20121214000477 |
News Archive
Aeterna Zentaris Inc. today announced that an independent Data Safety Monitoring Board has recommended discontinuing the ongoing Phase 3 study comparing the efficacy and safety of perifosine to placebo when combined with bortezomib (Velcade) and dexamethasone in patients with relapsed or relapsed/refractory multiple myeloma.
Implantable fibers have been an enormous boon to brain research, allowing scientists to stimulate specific targets in the brain and monitor electrical responses.
A team of scientists from the USA and Canada recently characterized the cross-neutralizing potency of anti-SARS-CoV-2 antibodies isolated from COVID-19 patients. The findings reveal that some of the isolated antibodies targeting the spike RBD and the S2 subunit are capable of cross-neutralizing other members of the human beta-coronavirus family.
At the 1st annual Society for Laboratory Automation and Screening Conference in San Diego (Booth #711), PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, will be showcasing several new drug discovery technologies and applications - including innovative products based on the Company's ALPHA technology and LANCE Ultra technologies for epigenetics research.
454 Life Sciences, a majority-owned subsidiary of CuraGen Corporation, announced today that its proprietary whole genome sequencing technology was used by scientists at Johnson & Johnson Pharmaceutical Research & Development L.L.C. (J&JPRD) to help understand the basis of tuberculosis drug resistance.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Shawn Wade Bryant, PSYD 839 W. Court St., Suite 4, Beatrice, NE 68310 Ph: (402) 228-6446 | Dr Shawn Wade Bryant, PSYD 839 W. Court St., Suite 4, Beatrice, NE 68310 Ph: (402) 228-6446 |
News Archive
Aeterna Zentaris Inc. today announced that an independent Data Safety Monitoring Board has recommended discontinuing the ongoing Phase 3 study comparing the efficacy and safety of perifosine to placebo when combined with bortezomib (Velcade) and dexamethasone in patients with relapsed or relapsed/refractory multiple myeloma.
Implantable fibers have been an enormous boon to brain research, allowing scientists to stimulate specific targets in the brain and monitor electrical responses.
A team of scientists from the USA and Canada recently characterized the cross-neutralizing potency of anti-SARS-CoV-2 antibodies isolated from COVID-19 patients. The findings reveal that some of the isolated antibodies targeting the spike RBD and the S2 subunit are capable of cross-neutralizing other members of the human beta-coronavirus family.
At the 1st annual Society for Laboratory Automation and Screening Conference in San Diego (Booth #711), PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, will be showcasing several new drug discovery technologies and applications - including innovative products based on the Company's ALPHA technology and LANCE Ultra technologies for epigenetics research.
454 Life Sciences, a majority-owned subsidiary of CuraGen Corporation, announced today that its proprietary whole genome sequencing technology was used by scientists at Johnson & Johnson Pharmaceutical Research & Development L.L.C. (J&JPRD) to help understand the basis of tuberculosis drug resistance.
› Verified 4 days ago
Dr. Meredith Lynn Griffin, PSYD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 1123 N 9th St, Beatrice, NE 68310 Phone: 402-228-3386 Fax: 402-228-2004 | |
Dr. Leland Carl Zlomke, PH.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 110 N 9th St, Beatrice, NE 68310 Phone: 402-483-6990 Fax: 402-483-7045 | |
Ken Maguire, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 710 Garfield St, Beatrice, NE 68310 Phone: 402-806-0852 | |
Virginia D Swartz, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1123 N 9th St, Beatrice, NE 68310 Phone: 402-228-3386 Fax: 402-228-2004 | |
Dr. Arynne Gabrielle Horton, LP Psychologist Medicare: Medicare Enrolled Practice Location: 4800 Hospital Pkwy, Beatrice, NE 68310 Phone: 402-559-6408 Fax: 402-559-5737 | |
James K Fruehling, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 900 W Court St, Beatrice, NE 68310 Phone: 402-223-5277 |